TSVT 2seventy bio Inc

  1. Stocks
  2. Healthcare
  3. NASDAQ: TSVT

Price (delayed)

$4.76

Market cap

$244.24M

P/E Ratio

N/A

Dividend/share

N/A

EPS

-$4.42

Enterprise value

$425.96M

Highlights
TSVT's debt is down by 5% YoY
TSVT's EPS is up by 38% year-on-year but it is down by 17% since the previous quarter
2seventy bio's gross profit has decreased by 35% QoQ but it has increased by 11% YoY
The equity has declined by 18% year-on-year and by 17% since the previous quarter
2seventy bio's gross margin has decreased by 5% from the previous quarter
Sector: Healthcare
Industry: Biotechnology
Peers: OMER OMGA

Key stats

What are the main financial stats of TSVT
Market
Shares outstanding
51.31M
Market cap
$244.24M
Enterprise value
$425.96M
Valuations
Price to earnings (P/E)
N/A
Price to book (P/B)
0.94
Price to sales (P/S)
2.34
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
4.24
Earnings
Revenue
$100.39M
EBIT
-$217.57M
EBITDA
-$207.29M
Free cash flow
-$180.72M
Per share
EPS
-$4.42
Free cash flow per share
-$3.67
Book value per share
$5.04
Revenue per share
$2.04
TBVPS
$11.34
Balance sheet
Total assets
$565.43M
Total liabilities
$310.13M
Debt
$256.67M
Equity
$255.3M
Working capital
$177.99M
Liquidity
Debt to equity
1.01
Current ratio
3.98
Quick ratio
3.85
Net debt/EBITDA
-0.88
Margins
EBITDA margin
-206.5%
Gross margin
83.1%
Net margin
-216.7%
Operating margin
-236.5%
Efficiency
Return on assets
-32.8%
Return on equity
-65.4%
Return on invested capital
-29.8%
Return on capital employed
-43%
Return on sales
-216.7%
Dividend
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A

TSVT stock price

How has the 2seventy bio stock price performed over time
Intraday
-3.45%
1 week
12%
1 month
-4.42%
1 year
-52.64%
YTD
11.48%
QTD
-11.03%

Financial performance

How have 2seventy bio's revenue and profit performed over time
Revenue
$100.39M
Gross profit
$83.47M
Operating income
-$237.37M
Net income
-$217.57M
Gross margin
83.1%
Net margin
-216.7%
TSVT's net margin has shrunk by 72% QoQ but it is up by 22% YoY
2seventy bio's operating margin has plunged by 69% from the previous quarter but it has increased by 18% YoY
2seventy bio's gross profit has decreased by 35% QoQ but it has increased by 11% YoY
2seventy bio's revenue has decreased by 31% QoQ but it has increased by 10% YoY

Growth

What is 2seventy bio's growth rate over time

Valuation

What is 2seventy bio stock price valuation
P/E
N/A
P/B
0.94
P/S
2.34
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
4.24
TSVT's EPS is up by 38% year-on-year but it is down by 17% since the previous quarter
The equity has declined by 18% year-on-year and by 17% since the previous quarter
TSVT's P/B is 6% below its last 4 quarters average of 1.0
2seventy bio's revenue has decreased by 31% QoQ but it has increased by 10% YoY
TSVT's P/S is 10% below its last 4 quarters average of 2.6

Efficiency

How efficient is 2seventy bio business performance
TSVT's return on sales has dropped by 72% since the previous quarter but it is up by 22% year-on-year
The ROE has contracted by 23% from the previous quarter but it has grown by 6% YoY
The ROIC has contracted by 22% from the previous quarter but it has grown by 14% YoY
2seventy bio's ROA has decreased by 22% from the previous quarter but it has increased by 3% YoY

Dividends

What is TSVT's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A

There are no recent dividends present for TSVT.

Financial health

How did 2seventy bio financials performed over time
TSVT's total assets is 82% greater than its total liabilities
TSVT's total assets is down by 14% year-on-year and by 12% since the previous quarter
2seventy bio's total liabilities has decreased by 10% YoY and by 7% from the previous quarter
2seventy bio's debt to equity has increased by 19% QoQ and by 16% YoY
The equity has declined by 18% year-on-year and by 17% since the previous quarter

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.